Since SARS-CoV-2 is a virus, many researchers have focused on repositioning approved antiviral drugs that were developed for earlier outbreaks like MERS, SARS, and West Nile virus.
Kwa kuwa SARS-CoV-2 ni virusi, uzingatifu mkubwa wa kisayansi umejikita kurudisha dawa za kuzuia virusi ambazo zilikuwa zimetengenezwa kwa ajili ya milipuko ya awali kama vile virusi vya MERS, SARS, na West Nile.